全文获取类型
收费全文 | 2180篇 |
免费 | 100篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 70篇 |
妇产科学 | 49篇 |
基础医学 | 169篇 |
口腔科学 | 25篇 |
临床医学 | 219篇 |
内科学 | 596篇 |
皮肤病学 | 53篇 |
神经病学 | 38篇 |
特种医学 | 345篇 |
外科学 | 208篇 |
综合类 | 25篇 |
预防医学 | 47篇 |
眼科学 | 21篇 |
药学 | 77篇 |
中国医学 | 2篇 |
肿瘤学 | 393篇 |
出版年
2023年 | 10篇 |
2022年 | 15篇 |
2021年 | 41篇 |
2020年 | 21篇 |
2019年 | 26篇 |
2018年 | 35篇 |
2017年 | 30篇 |
2016年 | 22篇 |
2015年 | 41篇 |
2014年 | 49篇 |
2013年 | 78篇 |
2012年 | 92篇 |
2011年 | 81篇 |
2010年 | 65篇 |
2009年 | 125篇 |
2008年 | 92篇 |
2007年 | 119篇 |
2006年 | 87篇 |
2005年 | 80篇 |
2004年 | 62篇 |
2003年 | 49篇 |
2002年 | 39篇 |
2001年 | 47篇 |
2000年 | 38篇 |
1999年 | 37篇 |
1998年 | 78篇 |
1997年 | 90篇 |
1996年 | 110篇 |
1995年 | 71篇 |
1994年 | 69篇 |
1993年 | 57篇 |
1992年 | 31篇 |
1991年 | 25篇 |
1990年 | 30篇 |
1989年 | 47篇 |
1988年 | 44篇 |
1987年 | 39篇 |
1986年 | 48篇 |
1985年 | 42篇 |
1984年 | 14篇 |
1983年 | 17篇 |
1982年 | 15篇 |
1981年 | 9篇 |
1980年 | 13篇 |
1979年 | 17篇 |
1978年 | 20篇 |
1977年 | 11篇 |
1976年 | 14篇 |
1975年 | 17篇 |
1974年 | 10篇 |
排序方式: 共有2338条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Complete testicular feminisation syndrome in three sisters 总被引:1,自引:0,他引:1
5.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
6.
D Pantazopoulos P Karagiannakos F Sofras A Kostakopoulos C Deliveliotis C Dimopoulos 《Urology》1990,36(3):255-259
The normal urothelium is covered by a glycosaminoglycan (GAG) layer which acts as a barrier to the adhesion of crystals. Destruction of the GAG layer increases the number of adhered crystals, and it is therefore assumed that it promotes crystal growth and stone formation. Intravesical instillation of pentosanpolysulfate, an exogenous glycosaminoglycan, after destruction of this layer reduces the adhesion of crystals to the urothelium. Intramuscular administration of carbenoxolone sodium following the experimental destruction of the GAG layer increases the rate of healing of the layer and reduces the number of adhered crystals. 相似文献
7.
Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma 总被引:1,自引:0,他引:1
Meletios A. Dimopoulos Kay B. Delasalle Richard Champlin Raymond Alexanian 《British journal of haematology》1993,83(2):240-244
Few effective regimens are available for patients with advanced multiple myeloma resistant to or relapsing after both alkylating agents and VAD. We treated 52 patients with advanced and refractory multiple myeloma with the combination of cyclophosphamide (3.0 g/m2 ) and etoposide (900 mg/m2 ) followed by GM-CSF at a daily dose of 0.125 mg/m2 until recovery of granulocytes. 42% of patients responded with a median time of 19 d for recovery of granulocytes to 0.5 x 109 /1 and a 4% mortality rate. Eight responding patients received a second myeloablative treatment supported by either autologous bone marrow (six patients) or blood stem cells (two patients). The median survival time for all patients was 11 months and the median remission time for responding patients was 8 months. The combination of cyclophosphamide and etoposide provided an effective rescue treatment for many patients with advanced multiple myeloma resistant to conventional therapies. This programme also allowed early marrow or blood stem cell collection in support of subsequent myeloablative therapy for selected patients. 相似文献
8.
JC Sitek† M Loeb‡ JR Ronnevig¶ 《Journal of the European Academy of Dermatology and Venereology》2007,21(7):891-896
BACKGROUND: Since 1997, a number of trials have shown promising results in treating generalized vitiligo with narrowband ultraviolet B (UVB) both in adults and children. However, there is little knowledge concerning the duration and permanency of the treatment-induced repigmentation. OBJECTIVE: Our main objective was to perform a follow-up trial of successfully treated patients receiving narrowband UVB for generalized vitiligo. METHODS: We have investigated to what degree the treatment-induced repigmentation remains stable for up to 2 years post-treatment. We performed an initial open trial including 31 patients with generalized vitiligo. They received narrowband UVB thrice weekly for up to 12 months. Patients experiencing > 75% repigmentation were defined responders and were included in the follow-up trial. Responders were followed every 6 months for up to 2 years after cessation of treatment. We observed the pigmentation status and registered any changes indicating loss of pigmentation and relapse. RESULTS: Eleven of the 31 treated patients were included in the follow-up trial. Six patients had relapse and five patients had stable response 24 months after cessation of treatment. Four out of six relapses were within 6 months post-treatment. CONCLUSION: In our study population of 31 patients with generalized vitiligo, five patients (16%) experienced > 75% stable repigmentation 2 years after cessation of a treatment programme of up to 1 years narrowband UVB therapy. 相似文献
9.
Ongoing pregnancies after intracytoplasmic injection using cryopreserved testicular spermatozoa 总被引:4,自引:2,他引:2
Perraguin-Jayot S; Audebert A; Emperaire JC; Parneix I 《Human reproduction (Oxford, England)》1997,12(12):2706-2709
We report two clinical pregnancies occurring after intracytoplasmic sperm
injection (ICSI) using cryopreserved spermatozoa obtained from testicular
biopsy, made in two different infertility situations in our clinic. The
first patient showed a secretory azoospermia associated with elevated serum
follicular stimulating hormone (FSH) level and spermiogenesis maturation
arrest. The second patient was affected by azoospermia resulting from
bilateral epididymal obstruction. Spermatozoa present in the wet
preparation of testicular biopsy made on the day of scrotal exploration
were cryopreserved within the testicular tissue for both men.
Intracytoplasmic injections were performed at a later date, using
spermatozoa prepared from frozen-thawed tissues. In each case, three
embryos were obtained and transferred in utero. The transfers resulted in a
twin pregnancy for the first case, and in a singleton pregnancy for the
second. Living foetuses were seen in the ultrasound scan at the 7th week
and both pregnancies are proceeding to date beyond 30 weeks without
complications.
相似文献
10.